These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2128141)

  • 1. Normal platelet function, but increased platelet activation in vivo in diabetic patients.
    Tomaselli L; Cerletti C; de Gaetano G; Notarbartolo A; Davì G; Pupillo M
    Thromb Haemost; 1990 Dec; 64(4):604. PubMed ID: 2128141
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane and 6-oxo-PGF1 alpha in the plasma of patients with diabetes type I and II.
    Rösen P; Hohl C; Tschöpe D; Körner A; Halfmann U; Berger M
    Prog Clin Biol Res; 1987; 242():247-52. PubMed ID: 3671386
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus.
    Jenkins AJ; Gosmanova AK; Lyons TJ; May KD; Dashti A; Baker MZ; Olansky L; Aston CE; Dale GL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):e8-10. PubMed ID: 18508150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-leukocyte-cross-talk in diabetes mellitus.
    Tschoepe D; Rauch U; Schwippert B
    Horm Metab Res; 1997 Dec; 29(12):631-5. PubMed ID: 9497901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation and cyclo-and lipoxygenase-activities in diabetes type II.
    Rösen P; Tschöpe D; Kayser S; Kaufmann L
    Prog Clin Biol Res; 1989; 301():359-63. PubMed ID: 2508108
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
    Triolo G; Davì G; Giardina E; Cardella F; Meli F; Strano A; Bompiani GD
    Diabetes Res; 1989 Jan; 10(1):1-5. PubMed ID: 2503285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification mechanisms in platelet activation and arterial thrombosis.
    De Clerck FF; Janssen PA
    J Hypertens Suppl; 1990 Dec; 8(7):S87-93. PubMed ID: 2128890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase inhibition of platelet activation.
    Cohen Z; Davis-Gorman G; McDonagh PF; Ritter L
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):305-9. PubMed ID: 18469552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2: its generation and role in platelet activation.
    Arita H; Nakano T; Hanasaki K
    Prog Lipid Res; 1989; 28(4):273-301. PubMed ID: 2534976
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein composition in resting and activated platelets of type I diabetic patients.
    Maresca M; Buzzi E; Piana A; Armani U; Leoncini G
    Diabete Metab; 1989; 15(5):242-6. PubMed ID: 2630377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of intracellular glutathione during platelet thromboxane synthesis in diabetes.
    Thomas G; Lucas FV; Schumacher OP; Skrinska V
    Prostaglandins Leukot Med; 1986 Apr; 22(1):117-28. PubMed ID: 3459196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.
    Takahashi R; Morita I; Saito Y; Ito H; Murota S
    Diabetologia; 1984 Feb; 26(2):134-7. PubMed ID: 6425101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report: Amino acid profile in platelets of diabetic patients.
    De Luca G; Calpona PR; Caponetti A; Macaione V; Di Benedetto A; Cucinotta D; Di Giorgio RM
    Metabolism; 2001 Jul; 50(7):739-41. PubMed ID: 11436175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and platelet half-life].
    Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
    Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
    [No Abstract]   [Full Text] [Related]  

  • 20. [Platelet spreading in diabetes mellitus].
    Syrbe G; Jütte A; Jorke D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):935-44. PubMed ID: 2467865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.